ARCHIVES

Part One Of A Two-Part Interview With NCI Director Harold Varmus

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

New Research Training Act May Permit NCI To Help fill Clinical Gaps In Radiotherapy, Medical Oncology

July 26, 1974

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

In Brief: NASA Procurement Specialist Names NEW NCI Contracts Chief; NIH Delays CREG Approval

January 3, 1975

Two Workshops To Look For New Research Areas

October 29, 1976

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981